Estudio de pembrolizumab más carboplatino y paclitaxel como tratamiento de primera línea del carcinoma de células escamosas de cabeza y cuello recurrente/metastásico
The goal of this study is to evaluate the efficacy and safety of pembrolizumab combined with carboplatin and paclitaxel as first line treatment in participants with recurrent/metastatic head and neck squamous